A pilot study of the efficacy of a bruton's tyrosine kinase inhibitor in the treatment of dogs with pemphigus foliaceus

被引:0
|
作者
Murrell, D. [1 ,2 ]
Gourlay, S. M. [3 ]
Hill, R. J. [3 ]
Bisconte, A. [3 ]
Francesco, M. [3 ]
Smith, P. [4 ]
Karr, D. [3 ]
Outerbridge, C. [5 ]
Varjonen, K. [5 ]
Goodale, E. C. [5 ]
Borjesson, D. [5 ]
Werth, V. P. [6 ]
Nuun, P. A. [3 ]
White, S. D. [5 ]
机构
[1] Univ New South Wales, St George Hosp, Kogarah, NSW, Australia
[2] Univ New South Wales, Sydney, NSW, Australia
[3] Principia Biopharma, San Francisco, CA USA
[4] d3 Med Inc, Parsippany, NJ USA
[5] UC Davis Vet Med Teaching Hosp, Davis, CA USA
[6] Univ Penn, Dept Dermatol, VAMC, Corporal Michael J Crescenz Philadelphia, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:73 / 73
页数:1
相关论文
共 50 条
  • [1] Efficacy of a Bruton's Tyrosine Kinase Inhibitor (PRN-473) in the treatment of canine pemphigus foliaceus
    Goodale, Elizabeth C.
    Varjonen, Katarina E.
    Outerbridge, Catherine A.
    Bizikova, Petra
    Borjesson, Dori
    Murrell, Dedee F.
    Bisconte, Angelina
    Francesco, Michelle
    Hill, Ronald J.
    Masjedizadeh, Mohammad
    Nunn, Philip
    Gourlay, Steven G.
    White, Stephen D.
    VETERINARY DERMATOLOGY, 2020, 31 (04) : 291 - +
  • [2] Open trial of Bruton's tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus
    Goodale, Elizabeth C.
    White, Stephen D.
    Bizikova, Petra
    Borjesson, Dori
    Murrell, Dedee F.
    Bisconte, Angelina
    Francesco, Michelle
    Hill, Ronald J.
    Masjedizadeh, Mohammad
    Nunn, Philip
    Gourlay, Steven G.
    Jordan, Tyler J. M.
    Emery, Carolyn B.
    Outerbridge, Catherine A.
    VETERINARY DERMATOLOGY, 2020, 31 (05) : 410 - +
  • [3] A new treatment for autoimmune blistering diseases - the efficacy of the Bruton's tyrosine kinase inhibitor PRN473 in canine pemphigus foliaceus
    Outerbridge, Catherine
    White, Stephen
    Varjonen, Katarina
    Goodale, Elizabeth
    Borjesson, Dori
    Murrell, Dedee
    Bisconte, Angelina
    Hill, Ronald
    Masjedizadeh, Mohammad
    Gourlay, Steven
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB141 - AB141
  • [4] Efficacy and safety of Bruton's tyrosine kinase inhibitors in the treatment of pemphigus: A comprehensive literature review and future perspective
    Ghane, Yekta
    Heidari, Nazila
    Heidari, Amirhossein
    Sadeghi, Sara
    Goodarzi, Azadeh
    HELIYON, 2023, 9 (12)
  • [5] Bruton's Tyrosine Kinase Inhibition in Pemphigus: An Embattled Frontier
    Payne, Aimee S.
    Vieira, Silvio Manfredo
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : 1667 - 1670
  • [6] Bruton tyrosine kinase inhibition warrants further study for pemphigus
    Drucker, A. M.
    Shear, N. H.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (04) : 691 - 692
  • [7] Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus
    Patsatsi, Aikaterini
    Murrell, Dedee F. F.
    FRONTIERS IN MEDICINE, 2021, 8
  • [9] Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
    Woyach, Jennifer A.
    Furman, Richard R.
    Liu, Ta-Ming
    Ozer, Hatice Gulcin
    Zapatka, Marc
    Ruppert, Amy S.
    Xue, Ling
    Li, Daniel Hsieh-Hsin
    Steggerda, Susanne M.
    Versele, Matthias
    Dave, Sandeep S.
    Zhang, Jenny
    Yilmaz, Ayse Selen
    Jaglowski, Samantha M.
    Blum, Kristie A.
    Lozanski, Arletta
    Lozanski, Gerard
    James, Danelle F.
    Barrientos, Jacqueline C.
    Lichter, Peter
    Stilgenbauer, Stephan
    Buggy, Joseph J.
    Chang, Betty Y.
    Johnson, Amy J.
    Byrd, John C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (24): : 2286 - 2294
  • [10] Novel leflunomide analog inhibitor of Bruton's tyrosine kinase
    Mahajan, S
    Ghosh, S
    Sudbeck, E
    Zheng, YG
    Downs, S
    Uckun, FM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U283 - U283